GSK recalls popular heartburn medicine Zantac : U.K. medicines watchdog

GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Peter Denson, 66, a retired coach engineer from Kent, suffered 20 years of seemingly harmless hiccups, burping and heartburn. He was shocked to be diagnosed with oesophageal cancer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
(AP) — Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination. The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug. In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor. Several drugstore chains have already removed Zantac and generic ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Consumer Health News Recall Zantac Source Type: news
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The company ’s announcement follows decisions by Walgreens, CVS and others to remove the drug from their shelves and after other manufacturers recalled their products.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Sanofi SA Drugs (Pharmaceuticals) Cancer Hazardous and Toxic Substances Food and Drug Administration Recalls and Bans of Products Heartburn your-feed-healthcare Zantac United States Canada Source Type: news
As anticipated, recall of the popular heartburn medicine ranitidine (Zantac) has expanded. But we still have more questions than answers. As I mentioned in my original blog post on this topic, the online pharmacy Valisure, which originally alerted the FDA to the issue, found what they called “extremely high levels” of the probable cancer-causing substance N-nitrosodimethylamine (NDMA) in ranitidine products. The FDA has indicated that its own preliminary testing has detected low levels of NDMA in ranitidine. Testing methods may have influenced NMDA results The FDA has clarified that the testing method that...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Source Type: blogs
The pharmaceutical giant had already pulled its common heartburn drug from shelves in Ireland, India and Hong Kong up to two weeks ago. Zantac is still available over-the-counter in Britain.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled the drugs off shelves, following an FDA alert about an "impurity" in the medication. Dr. Jon LaPook recently spoke to two groups of researchers who suspect the problem could be serious for consumers.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
More News: Cancer | Cancer & Oncology | Health | Heartburn | UK Health